v3.22.2.2
Segment Information
9 Months Ended
Sep. 30, 2022
Segment Information  
Segment Information

Note 16. Segment Information

As a result of the Company’s transition to a pure-play health and wellness services company, the Company currently has four reportable operating segments: XpresSpa, XpresTest, Treat and HyperPointe, acquired in January 2022. The Company analyzes the results of the Company’s business through the four reportable segments. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public.  The Treat segment provides access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place, as well as book appointments in the Company’s on-site wellness centers as they reopen. The HyperPointe segment provides a broad range of service and support options for its customers, including technical support services and advanced services. The chief operating decision maker evaluates the operating results and performance of the Company’s segments through operating income. Expenses that can be specifically identified with a segment have been included as deductions in determining operating income. Any remaining expenses and other charges are included in Corporate and Other.

For the three months ended

September 30, 

    

2022

    

2021

Revenue

 

  

 

  

XpresSpa

$

3,557

$

1,416

XpresTest

6,079

25,351

Treat

425

HyperPointe

675

Corporate and other

 

 

Total revenue

$

10,736

$

26,767

Operating income (loss)

 

  

 

  

XpresSpa

$

(2,508)

$

(1,595)

XpresTest

(1,692)

12,015

Treat

(1,282)

(2,305)

HyperPointe

(193)

Corporate and other

 

(1,979)

 

(1,058)

Total operating (loss) income

$

(7,654)

$

7,057

Depreciation & Amortization

XpresSpa

$

364

$

340

XpresTest

 

576

 

509

Treat

520

HyperPointe

86

Corporate and other

 

18

 

3

Total Depreciation & Amortization

$

1,564

$

852

For the nine months ended

September 30, 

    

2022

    

2021

Revenue

 

  

 

  

XpresSpa

$

9,490

$

2,172

XpresTest

35,928

42,199

Treat

1,110

HyperPointe

1,853

Corporate and other

 

 

Total revenue

$

48,381

$

44,371

Operating loss

 

  

 

  

XpresSpa

$

(8,921)

$

(4,828)

XpresTest

2,576

14,597

Treat

(4,038)

(4,115)

HyperPointe

(745)

Corporate and other

 

(6,744)

 

(3,719)

Total operating (loss) income

$

(17,872)

$

1,935

Depreciation & Amortization

XpresSpa

$

1,065

$

931

XpresTest

 

1,711

 

1,604

Treat

1,287

HyperPointe

243

Corporate and other

 

23

 

7

Total depreciation & amortization

$

4,329

$

2,542

Capital Expenditures

XpresSpa

$

1,413

$

706

XpresTest

 

675

 

3,984

Treat

3,329

HyperPointe

Corporate and other

 

55

 

77

Total capital expenditures

$

5,472

$

4,767

September 30, 

December 31, 

2022

2021

Long-lived Assets

XpresSpa

$

14,203

8,419

XpresTest

 

112

2,246

Treat

6,280

2,700

HyperPointe

 

123

Corporate and other

 

522

1,132

Total long-lived Assets

$

21,240

$

14,497

September 30, 

December 31, 

2022

    

2021

Assets

 

  

 

  

XpresSpa

$

21,348

$

12,351

XpresTest

 

5,356

 

19,349

Treat

9,822

5,918

HyperPointe

7,126

Corporate and other

 

41,324

 

89,648

Total assets

$

84,976

$

127,266